Circulating adipokines and the protective effects of hyperinsulinemia in inflammatory bowel disease.
about
Inflammation Meets Metabolic Disease: Gut Feeling Mediated by GLP-1Therapeutic Potential to Modify the Mucus Barrier in Inflammatory Bowel DiseaseBacterial translocation - impact on the adipocyte compartmentThe role of physical exercise in inflammatory bowel diseaseAdipokines and the role of visceral adipose tissue in inflammatory bowel diseaseInteraction of obesity and inflammatory bowel diseaseLow circulating maternal adiponectin in patients with pyelonephritis: adiponectin at the crossroads of pregnancy and infection.Beneficial Effect of Voluntary Exercise on Experimental Colitis in Mice Fed a High-Fat Diet: The Role of Irisin, Adiponectin and Proinflammatory BiomarkersSerum adipokines in inflammatory bowel disease.Adipokines: biofactors from white adipose tissue. A complex hub among inflammation, metabolism, and immunity.Moderate exercise training attenuates the severity of experimental rodent colitis: the importance of crosstalk between adipose tissue and skeletal muscles.Adipokines as drug targets in diabetes and underlying disturbances.The combination of high-fat diet-induced obesity and chronic ulcerative colitis reciprocally exacerbates adipose tissue and colon inflammationNutritional modulators of ulcerative colitis: clinical efficacies and mechanistic viewSerum Concentrations of Insulin, Ghrelin, Adiponectin, Leptin, Leptin Receptor and Lipocalin-2 in Children with Celiac Disease Who Do and Do Not Adhere to a Gluten-Free Diet.Retinol Binding Protein 4 in children with Inflammatory Bowel Disease: a negative correlation with the disease activity.Genome-wide analysis identifies colonic genes differentially associated with serum leptin and insulin concentrations in C57BL/6J mice fed a high-fat diet.Diverse roles of leptin in the gastrointestinal tract: modulation of motility, absorption, growth, and inflammation.Nutritional and probiotic supplementation in colitis models.The bone and fat connection in inflammatory bowel diseases.Metabolic inflammation in inflammatory bowel disease: crosstalk between adipose tissue and bowel.NAMPT serum levels are selectively elevated in acute infectious disease and in acute relapse of chronic inflammatory diseases in children.Fatty acid synthase modulates intestinal barrier function through palmitoylation of mucin 2.Plasma ghrelin and leptin in patients with inflammatory bowel disease and its association with nutritional status.Are adipocytokines inflammatory or metabolic mediators in patients with inflammatory bowel disease?Unraveling the link between leptin, ghrelin and different types of colitisEndocrine and metabolic manifestations in inflammatory bowel diseaseCardiotrophin-1 Regulates Adipokine Production in 3T3-L1 Adipocytes and Adipose Tissue From Obese Mice.Maintaining adequate nutrition, not probiotic administration, prevents growth stunting and maintains skeletal muscle protein synthesis rates in a piglet model of colitis.The effect of body weight on the severity and clinical course of ulcerative colitis.Circulating leptin and adiponectin and their relation to glucose metabolism in children with Crohn's disease and ulcerative colitis.High serum vaspin concentrations in patients with ulcerative colitis.Association Between Adipokines Levels with Inflammatory Bowel Disease (IBD): Systematic Reviews.Impact of Bariatric Surgery on Outcomes of Patients with Inflammatory Bowel Disease: a Nationwide Inpatient Sample Analysis, 2004-2014.Relation of the IGF/IGF1R system to autophagy in colitis and colorectal cancer.Serum levels and mesenteric fat tissue expression of adiponectin and leptin in patients with Crohn's disease.Nutritional strategy to prevent fatty liver and insulin resistance independent of obesity by reducing glucose-dependent insulinotropic polypeptide responses in mice.Favorable Effect of Anti-TNF Therapy on Insulin Sensitivity in Nonobese, Nondiabetic Patients with Inflammatory Bowel Disease.Serum Visfatin Levels in Ulcerative Colitis.Circulating levels of chemerin and adiponectin are higher in ulcerative colitis and chemerin is elevated in Crohn's disease.
P2860
Q26752511-501E991F-88E9-4B4E-A82F-284C20D5AEE0Q26771122-485C4EEB-7B42-4F83-BFAD-55716B4A809FQ26852238-A85E92AD-279C-4650-808D-9CA86F2DC87EQ26865777-09CAD900-190B-4F13-AD95-CDBFB009659DQ28070229-D6B96DCE-DABD-4CAE-A96F-F429CAF6C467Q28072225-A57EDB4C-1921-432A-8224-E7E74F77777AQ33575629-B8B10C77-0787-4864-A8D7-2E6A5FDCEA79Q33616994-2E85E877-6BC2-40C2-9FEA-67BF73ED7429Q33735303-1687DF89-FB7D-49D7-A638-930E470A7F05Q34228799-34E0328D-F02F-46FA-BB2E-F577588C0EC5Q35037497-D225C2BB-6448-4466-A125-C5B42D880F11Q35415815-ADA80D00-A9CF-4C2D-86F9-32A484368024Q35661869-F7179143-FD18-46B4-AC2C-931A1C73B2A3Q36637753-31C33491-4BCD-4DEA-B875-DB3990249872Q37066380-0AF8F089-B408-46FF-B1D5-5E2CD71DC02BQ37083027-3326F713-F1CC-43E7-9255-E66E4C688269Q37629433-6B25A8BA-EC75-440F-A8F6-E5B5C207A38AQ37800259-D82CB3C5-9AEF-4118-9FA0-B9F76A6FC339Q38021933-F9C470C9-57B5-4E75-8729-5EB0DEE0C367Q38225220-7B02193D-77A0-4AD9-8194-3698C9283E31Q38253468-A19AC368-2020-47DF-8DC5-7A47BDEBD803Q40081111-55847F90-9DCB-4386-AE04-8A2D8996C23FQ41484493-727059CF-CF60-4D69-9008-6569D04250A8Q42203617-34ECC364-A113-4B5A-B899-9A4BC6B0198EQ42370720-106B7E77-9CD3-4CDA-9D5D-24A996AD77E8Q42406608-F0A0E50A-B9EA-4FA6-9715-96725B7756D1Q42406756-73D82907-845E-493B-B35B-E0484E6272EEQ42807485-0720086C-91A6-4E88-B83A-BAB34F27BBB2Q42909606-30EBF30F-9926-4FAE-A722-6461AC2F7D11Q44211308-185C517F-1984-444F-8994-CC05AB268283Q45346768-03364EAA-9191-4AED-BB7E-F468A5450686Q46036744-0D3A94EC-AC0B-4660-80EB-21CAE5749349Q47584731-1263005B-0EC1-4CAE-933F-EDA61342CE25Q47765146-242BC5C1-2D9C-47DC-A380-BFF9BB3D78B3Q48553803-B424AF34-A5CC-441C-9C48-4F44FFD32873Q50899263-E29C40A2-EBA9-42CA-A61F-B6355F224094Q51039744-4F0B2140-CCD8-4A2A-9DAB-5D5AF8850B01Q51244473-B3FBE78E-1FE0-4CA1-A0E6-1CBE362825A8Q51565169-66F2F569-7DA7-4400-B55F-2CF16BEF9E46Q51617434-D5B688A8-0B65-4825-843B-6D3B170E3BE6
P2860
Circulating adipokines and the protective effects of hyperinsulinemia in inflammatory bowel disease.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh
2008年學術文章
@zh-hant
name
Circulating adipokines and the ...... in inflammatory bowel disease.
@en
Circulating adipokines and the ...... in inflammatory bowel disease.
@nl
type
label
Circulating adipokines and the ...... in inflammatory bowel disease.
@en
Circulating adipokines and the ...... in inflammatory bowel disease.
@nl
prefLabel
Circulating adipokines and the ...... in inflammatory bowel disease.
@en
Circulating adipokines and the ...... in inflammatory bowel disease.
@nl
P2093
P50
P1433
P1476
Circulating adipokines and the ...... in inflammatory bowel disease.
@en
P2093
Brigitte M Winklhofer-Roob
Carsten Buning
Ekkehart Dietz
Herbert Lochs
Johann Ockenga
Lennart Schaper
Susanne Hengstermann
Thomas Koernicke
P304
P356
10.1016/J.NUT.2008.07.020
P577
2008-10-11T00:00:00Z